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Linkage studies were performed in a large family with an autosomal dominant phenotype characterized by ne-
phropathy and hypertension. In this family of Iraqi Jewish origin, the nephropathy develops into progressive renal
failure. By performing a genomewide linkage search, we localized the disease gene to chromosome 1q21; the highest
LOD score was obtained for the marker at locus D1S305, which yielded a maximum LOD score of 4.71 at a
recombination fraction of 0. Recombination mapping defined an interval of ∼11.6 cM, between the markers at
loci D1S2696 and D1S2635, that contains the disease gene. Localization of the disease-causing gene in this family
represents a necessary step toward isolation of the defective gene and toward a deeper understanding of the
mechanisms of hypertension and progressive renal failure.
Introduction
Several distinct clinical phenotypes have been described
that lead to autosomal dominantly inherited end-stage
renal failure. Examples include Alport syndrome (Jeffer-
son et al. 1997) and non-Alport nephritis (Ben-Ishay et
al. 1967; Dockhorn 1967; Albert et al. 1969; Gauthier
et al. 1989), nephronophthisis/medullary cystic kidney
disease (Goldman et al. 1966), interstitial nephritis (Rich-
mond et al. 1981), adult polycystic kidney disease, and
various inherited glomerulopathies (Faubert and Porush
1997). Genetic loci for many of these conditions have
been defined (Christodoulou et al. 1998;Winn et al. 1999;
Scolari et al. 1999), and the disease genes have been iso-
lated for several disorders in this group. The roles of the
defective proteins reveal that diverse mechanisms can pro-
duce these phenotypes, including defects in extracellular
matrix structural proteins, such as type IV collagen ab-
normalities in Alport syndrome; defects inmembranepro-
teins, such as the polycystins in adult polycystic kidney
disease (European Polycystic Kidney Disease Consortium
1994; Mochizuki et al. 1996); and defects in cytoskeletal
organization, as observed for abnormalities in a-actinin-
4 in familial focal segmental glomerulosclerosis (Kaplan
Received May 22, 2000; accepted for publication July 19, 2000;
electronically published August 4, 2000.
Address for correspondence and reprints: Dr. Mordechai Shohat,
Director, Department of Medical Genetics, Rabin Medical Center, Bei-
linson Campus, Petah Tikva 49100, Israel. E-mail: mshohat@ccsg
.tau.ac.il
 2000 by The American Society of Human Genetics. All rights reserved.
0002-9297/2000/6703-0012$02.00
et al. 2000). However, in many of the aforementioned
disorders there are additional, nonrenal manifestations,
such as deafness or ocular abnormalities. In forms of ne-
phropathy and hypertension without extrarenal findings
(e.g., MIM 161900), neither a locus nor a specific gene
defect has yet been defined.
In addition, genes responsible for at least two auto-
somal dominant forms of hypertension without ne-
phropathy have been found. Defects involving
CYP11B1 and CYP11B2 on chromosome 8 are re-
sponsible for glucocorticoid-suppressible hyperaldos-
teronism (Pascoe et al. 1992), and mutations in the gene
on chromosome 16 encoding the b subunit of the epi-
thelial sodium channel cause Liddle’s syndrome (Shim-
kets et al. 1994).
We have ascertained a large Israeli family of Iraqi
Jewish origin with an autosomal dominant form of
adult-onset nephropathy and hypertension. Hyperten-
sion was the presenting symptom in all patients. There
was progressive renal failure, and patients eventually
required hemodialysis followed by renal transplanta-
tion. The aims of the present study were to describe the
clinical features in the family and to determine the chro-
mosomal location of the defective gene by a genome-
wide linkage search.
Subjects and Methods
The Family and the Phenotype
The Institutional Review Board of the Rabin Medical
Center approved this study, and all subjects provided
written informed consent. The family included 14 af-
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Figure 1 Pedigree of the family with nephropathy-hypertension, showing the most likely haplotypes for the chromosome 1 markers.
Affected individuals are indicated by blackened symbols. Generations are indicated by Roman numerals on the left. Within each generation,
identifying numbers for individuals are indicated with Arabic numerals above each symbol. The haplotype linked to the phenotype is boxed.
For individual II-2, the genotypes are bracketed to indicate that they were inferred from those of his offspring. The order of and genetic distances,
in centimorgans, between the markers were D1S2726–9.5–D1S2696–2.2–D1S498–3.4–D1S305–6.0–D1S2635.
fected members over four generations (fig. 1). This study
included only family members who were aged 130 years,
and all of these underwent complete physical exami-
nation, blood pressure measurement, measurement of
serum creatinine and BUN levels, and urine testing. We
considered as affected those individuals with creatinine
levels of 12 mg/dl in two repeat measurements. All af-
fected individuals had either progressive renal failure or
marked hypertension (or both), in addition to the high
serum creatinine level. We determined that an individual
was unaffected only if the serum creatinine and BUN
levels were normal in two repeat measurements (serum
creatinine level !1.3 mg/dl), urine testing gave normal
results, there was no hypertension, and the individual
was 130 years old.
Eleven family members had end-stage renal failure,
which developed at ages 19–50 years. Seven affected
individuals (II-3, III-1, III-2, III-10, III-11, III-14, and
IV-1) have undergone renal transplantation, and three
affected members of the family are on either hemodi-
alysis (III-3 and III-7) or peritoneal dialysis (III-8). In
addition, we identified two individuals (III-13, aged 34
years, and III-9, aged 38 years) with hypertension (blood
pressure 180/130 and 160/110 mm Hg [systolic/dia-
stolic], respectively) and a high blood-creatinine level
(2.2 mg/dl and 2.8 mg/dl, respectively), without other
clinical evidence of renal failure. No extrarenal mani-
festations were found in any of the subjects.
All affected family members had marked hypertension
(diastolic pressure 105 mm Hg) at the time of diagnosis.
In at least two patients (II-3 and III-7), marked hyper-
tension had been evident for several years prior to onset
of high blood-creatinine levels and additional clinical
findings indicating renal failure. Several affected family
members underwent more extensive clinical investiga-
tion. Serum electrolytes were normal (sodium levels
143–145 meq/l) and, apart from reduced creatinine
clearance, urinalysis did not reveal evidence of any other
abnormalities, even in the later stages of the condition.
In two individuals (III-3 and IV-1), 24-h urine analysis
gave normal results for protein (140–147 mg/24 h), uric
acid, sodium, potassium, and calcium and was negative
for the presence of blood cells. Their blood-creatinine
levels were 5.8 mg/dl and 3.1 mg/dl, respectively. Renal
ultrasound findings were normal in all affected individ-
uals examined. No evidence for abnormalities in corti-
costeroid metabolism was seen in any affected members
of the family.
We reviewed the reports of the renal biopsies per-
formed on two affected individuals (III-3 and III-14),
both of whom had hypertension and reduced creatinine
clearance at the time of biopsy. Patient III-3 underwent
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Table 1
Two-Point LOD Scores Obtained between the Disease and Five Polymorphic Marker Loci Spanning the
Nephropathy-Hypertension Region on Chromosome 1q21-q22
MARKER
LOD SCORE AT v p
0 .01 .02 .03 .04 .05 .1 .15 .2 .3 .4
D1S2726  2.04 1.47 1.14 .92 .76 .30 .10 .003 .02 .04
D1S2696  2.82 1.96 1.74 1.14 .89 .21 .08 .22 .24 .10
D1S498 .83 .81 .80 .78 .77 .75 .67 .59 .50 .34 .17
D1S305 4.71 4.63 4.55 4.47 4.39 4.31 3.90 3.47 3.01 2.03
D1S2635  2.30 2.53 2.64 2.69 2.72 2.66 2.46 2.18 1.50 .67
renal biopsy at age 27 years, at which time blood pres-
sure was 160/110 mm Hg and serum creatinine level
was 1.4 mg/dl. Of 10 glomeruli examined, 7 were nor-
mal and 3 were sclerotic, and there was evidence of
interstitial fibrosis and mild tubular atrophy. Individual
III-14 underwent renal biopsy at age 26 years, when
blood pressure was 150/110 mm Hg and serum creati-
nine level was 1.7 mg/dl. On electron microscopy, apart
from mild thinning of the membranes, no significant
renal abnormalities were found in seven glomeruli or in
the medulla, nor were any abnormalities seen after im-
munofluorescence staining for IgG, IgA, IgM, C3, C4,
C1q, properdin, fibrinogen, and albumin.
Blood Samples
Blood samples for DNA testing were collected from
22 family members. With the exception of IV-1 and IV-
2, all the individuals in generation IV were !25 years of
age, and most were !18 years old. At the time of the
study all these individuals were healthy, but, since there
was no way to predict whether they would develop renal
problems or hypertension at a later stage, they were
excluded from participation in the study.
Genotyping
The LD20 linkage mapping set of fluorescently labeled
synthetic oligonucleotide primers was obtained from
ABI. Additional fluorescently labeled markers for can-
didate regions were also obtained from ABI. PCR am-
plification reactions were performed either singly or in
combination, under conditions recommended by the
manufacturer. PCR products were pooled and separated
on an ABI 373 stretch automated DNA sequencer. Ad-
ditional markers from chromosome 1 were derived from
the Whitehead Institute for Biomedical Research data-
base, and oligonucleotide primers for analysis of these
markers were obtained from Research Genetics.
Linkage Calculations
Two-point linkage analyses were conducted for all
markers. LOD scores were calculated with the MLINK
subroutine of the LINKAGE 5.1 package (Terwilliger
and Ott 1994), using a Pentium PC. The nephropathy-
hypertension phenotype was modeled as an autosomal
dominant, fully penetrant disease with an allele fre-
quency of .0001. Although genotypes could be inferred
for II-2, these were not included in the LOD score cal-
culations. Since marker allele frequencies in this popu-
lation are unknown, the allele frequencies for each
marker were set at 1/N, where N was the number of
alleles observed in the pedigree.
Results
Markers at the 206 autosomal loci from the ABI Prism
LD20 linkage mapping set, with an average spacing of
20 cM, were typed in the family. Two-point LOD scores
were calculated for each marker. There were 15 loci on
11 chromosomes that yielded a two-point LOD score
10 at a recombination fraction (v) of 0.1. For each of
these loci, flanking markers were typed. Among the
flanking markers, suggestive linkage was obtained only
for the marker at locus D1S2635, which yielded a max-
imum LOD score of 2.72 at .vp 0.05
Genotypes at loci for additional regional polymorphic
markers on chromosome 1 confirmed the initial linkage
result. Two-point LOD scores for these markers are
shown in table 1. The highest LOD score was obtained
for the marker at locus D1S305, which was fully in-
formative and yielded a maximum LOD score of 4.71
at . Genotypes for the chromosome 1 markers arevp 0
shown on the pedigree in figure 1, with haplotypes as-
signed by parsimony.
Recombination mapping defined a region of ∼11.6
cM, at chromosomal region 1q21, containing the dis-
ease gene. The proximal boundary at locus D1S2696
was established by recombinant events between
D1S2696 and D1S498, observed for individuals III-11
and III-14. The distal boundary at locus D1S2635 re-
flected a recombination between D1S305 and D1S2635
for individual III-2.
Discussion
The data presented here have defined an ∼11.6-cM in-
terval at chromosome 1q21 containing a locus for an
autosomal dominant form of nephropathy and hyper-
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tension that leads to end-stage renal failure. The renal
component of the phenotype was significant for the ab-
sence of renal cysts, specific urine abnormalities, or ex-
trarenal findings. Renal biopsy in two affected individ-
uals showed evidence of end-stage renal failure but did
not reveal a pathognomonic renal lesion. The most con-
sistent and significant finding in all patients was the
marked hypertension. Whether the hypertension was the
primary cause of the renal failure or was secondary to
an underlying renal defect is not clear.
On the basis of the inheritance pattern, the presence
of renal failure without extrarenal abnormalities, and
the frequent finding of hypertension, the phenotype in
this family is most similar to familial nephropathy
(MIM 161900). However, there is a wide range of phe-
notypic expression in families grouped in this entity,
suggesting the strong possibility of genetic heteroge-
neity. With the identification of a locus for familial ne-
phropathy, it will now be possible to assess both the
question of locus heterogeneity and the range of clinical
presentation among families in which the phenotype is
linked to the 1q21 region.
Of note are the striking uniform progression to renal
failure and the absence of proteinuria seen in this kin-
dred, which appear to distinguish this family from other
families with autosomal dominant focal segmental
glomerulosclerosis. Among families with familial ne-
phropathy, another Israeli family of Iraqi Jewish origin,
with similar clinical findings, has been reported (Ben-
Ishay et al. 1967). In that family, 20 affected individuals
were identified among 66 family members examined.
The affected individuals showed clinical findings similar
to findings in the patients described here except that
they also had mild proteinuria. Four patients in the
family underwent renal biopsy. One patient showed
normal histology, chronic glomerulonephritis was
found in two patients, and pyelonephritis with nephros-
clerosis was observed in the fourth. The authors con-
cluded that the histological studies were too limited and
inconsistent to warrant a conclusive pathologic diag-
nosis. Similar to the findings in our family, hypertension
was present 3–11 years prior to renal failure. Thus the
question of whether the hypertension was causative
rather than secondary to underlying renal disease could
not be resolved.
Christodoulou et al. (1998) localized a gene for au-
tosomal dominant medullary cystic kidney disease
(MCKD1) to chromosome 1q21 in two genetically re-
lated Cypriot families. The interval containing the
MCKD1 gene was flanked by markers D1S498 and
D1S2125, a region that overlaps with the interval con-
taining the familial nephropathy locus defined here.
However, on the basis of clinical findings, the two dis-
orders appear to represent distinct entities. In the pa-
tients with familial nephropathy, there was relatively
increased sodium preservation (blood and urine sodium
levels were in the normal range, at 143–145 meq/l and
107 mg/24 h, respectively), whereas, in the patients with
MCKD1, there was increased sodium excretion and hy-
ponatremia (with hypotension in the later stages). In
addition, medullary cysts have not been found in any
of the familial nephropathy patients in our kindred.
Whether the localization of the disease genes for these
two renal phenotypes reflects clustering of two genes
important for proper kidney function or results from
distinct types of mutations in a single gene remains to
be determined.
TheNPR1 gene, which encodes atrial natriuretic pep-
tide receptor 1, has been localized to the 1q21-q22 re-
gion (Lowe et al. 1990). The product of this gene is
involved in blood pressure regulation and is found in
the kidney, vasculature, and adrenal glands. Mice ho-
mozygous for a knockout mutation in the mouse or-
thologue had high blood pressure, cardiac hypertrophy,
and early death due to cardiac complications (Oliver et
al. 1997). The mice did not have nephritis or other
obvious abnormalities in the kidneys, although there
may not have been time for this to develop. A poly-
morphic allele of the human NPR1 gene has been as-
sociated with essential hypertension (Nakayama et al.
2000). Despite the apparent absence of kidney involve-
ment in both the mouse knockout strain and the patients
with essential hypertension, the role of the NPR1 gene
product in blood pressure control is intriguing and sug-
gests the possibility that distinct types of mutations in
the NPR1 gene could produce different phenotypes.
Therefore, NPR1 remains a candidate disease gene for
the nephropathy and hypertension phenotype present
in the family described here.
This report describes definition of a locus for a form
of nephropathy and hypertension that leads to end-stage
renal failure. Localization of the disease gene in this
family holds the promise of the eventual identification
of the defective gene and development of a deeper un-
derstanding of the relationship between hypertension
and progressive renal failure.
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